New insights into epithelial differentiation of human adipose-derived stem cells.
Baer PC., Döring C., Hansmann ML., Schubert R., Geiger H.
Laboratory Study on Chronic Kidney Disease, published in J Tissue Eng Regen Med (2011) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- J Tissue Eng Regen Med (2011)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 22162286
- DOI
- 10.1002/term.518
- Citations
- 19
Abstract (original English)
Although many studies using stem cells as therapeutic agents after renal failure have been published in recent years, our knowledge of the factors involved and the cellular mechanisms underlying their beneficial effect on organ regeneration is incomplete. A growing insight into these interactions would help to utilize the biological potential of stem cells for therapeutic approaches. It is here hypothesized that soluble factors released by tubular epithelial cells (TECs) induce epithelial differentiation in adipose-derived adult mesenchymal stem cells (ASCs). ASCs were therefore cultured in conditioned medium (CM) derived from TECs and the changes in expression genes towards an epithelial pattern were determined by microarray and qPCR analyses. The changes in gene expression were evaluated using Affymetrix HG-U133 Plus 2.0 arrays. Microarray-based screening revealed 117 genes differentially expressed in a significant manner after short-time incubation (3 days) of ASCs with CM, and four of these were solute carriers (SLCs). Changes in mRNA expression of these SLCs were verified by qPCR at several time points, additionally with four stem cell factors and five epithelial markers. qPCR analyses showed that expression of three of the SLCs rose significantly, whereas three of the four stem cell markers analysed decreased during 7 days of CM incubation. Moreover, a robust expression o
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review
Systematic Review on Chronic Kidney Disease, published in Ren Fail (2026) — summary generated from the PubMed abstract.
- 2026
Ren Fail - Level AMeta-analysisEurope PMC
Meta-analysis study of the therapeutic impact of Mesenchymal stem cells derived exosomes for chronic kidney diseases
Meta-analysis on Chronic Kidney Disease, published in Biochem Biophys Rep (2025) — summary generated from the PubMed abstract.
- 2025
Biochem Biophys Rep2 citations - Level ASystematic ReviewPubMed
Clinical Safety and Efficacy of Allogeneic Adipose Stem Cells: A Systematic Review of the Clinical Trials.
Systematic Review with a reported sample of 953 on Osteoarthritis, Chronic Kidney Disease, Scar, Autoimmune Research, published in Int J Mol Sci (2025) — summary generated from the PubMed abstract.
- 2025
- n = 953
Int J Mol Sci2 citations - Level ASystematic ReviewEurope PMC
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024
Systematic Review on Chronic Kidney Disease, Acute Kidney Injury, published in Front Immunol (2025) — summary generated from the PubMed abstract.
- 2025
Front Immunol2 citations - Level AMeta-analysisEurope PMC
Mesenchymal Stem Cells as Anti-Inflammatory Agents in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
Meta-analysis on Chronic Kidney Disease, Chronic Inflammation, published in Cells (2025) — summary generated from the PubMed abstract.
- 2025
Cells - Level AMeta-analysisEurope PMC
Protective role of exosomes in renal ischemia-reperfusion injury: a systematic review and meta-analysis
Meta-analysis on Chronic Kidney Disease, Acute Kidney Injury, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol1 citations